-
公开(公告)号:EP2844642B1
公开(公告)日:2019-11-13
申请号:EP13788352.6
申请日:2013-03-15
申请人: ARIAD PHARMACEUTICALS, INC. , Zhu, Xiaotian , Wang, Yihan , Shakespeare, William C. , Huang, Wei-Sheng , Dalgarno, David C.
发明人: ZHU, Xiaotian , WANG, Yihan , SHAKESPEARE, William, C. , HUANG, Wei-Sheng , DALGARNO, David, C.
IPC分类号: C07D239/48 , C07D403/12 , C07F9/6561 , C07F9/6584 , C07F9/6512 , C07F9/6521 , A61K31/505 , A61K31/506 , A61P35/00
-
公开(公告)号:EP2841062A4
公开(公告)日:2015-11-25
申请号:EP13782134
申请日:2013-03-12
申请人: ARIAD PHARMA INC , GOZGIT JOSEPH M , RIVERA VICTOR M , SHAKESPEARE WILLIAM C , ZHU XIAOTIAN , DALGARNO DAVID C
IPC分类号: A61K31/165 , A61K31/437 , A61K31/4985 , A61K31/5025 , A61K31/5377 , A61P35/00
CPC分类号: C07D487/04 , A61K31/437 , A61K31/496 , A61K31/4985 , A61K31/5025 , A61K31/5377 , C07D471/04 , C07D473/34
-
公开(公告)号:EP2841062A1
公开(公告)日:2015-03-04
申请号:EP13782134.4
申请日:2013-03-12
申请人: ARIAD PHARMACEUTICALS, INC. , Gozgit, Joseph M. , Rivera, Victor M. , Shakespeare, William C. , Zhu, Xiaotian , Dalgarno, David C.
发明人: GOZGIT, Joseph, M. , RIVERA, Victor, M. , SHAKESPEARE, William, C. , ZHU, Xiaotian , DALGARNO, David, C.
IPC分类号: A61K31/165
CPC分类号: C07D487/04 , A61K31/437 , A61K31/496 , A61K31/4985 , A61K31/5025 , A61K31/5377 , C07D471/04 , C07D473/34
摘要: The invention discloses methods and compositions for treating or preventing RAF kinase mediated diseases or conditions by administering a compound of Formula 1: or a pharmaceutically acceptable salt, solvate or hydrate thereof, wherein the variables are defined as herein.
摘要翻译: 本发明公开了通过施用式1的化合物或其药学上可接受的盐,溶剂化物或水合物来治疗或预防RAF激酶介导的疾病或病症的方法和组合物,其中变量如本文所定义。
-
4.
公开(公告)号:EP2844642A4
公开(公告)日:2015-11-18
申请号:EP13788352
申请日:2013-03-15
申请人: ARIAD PHARMA INC , ZHU XIAOTIAN , WANG YIHAN , SHAKESPEARE WILLIAM C , HUANG WEI-SHENG , DALGARNO DAVID C
IPC分类号: C07D239/48
CPC分类号: C07D239/48 , C07D403/12 , C07F9/65127 , C07F9/65217 , C07F9/65583 , C07F9/65586 , C07F9/6561 , C07F9/6584
-
5.
公开(公告)号:EP2844642A1
公开(公告)日:2015-03-11
申请号:EP13788352.6
申请日:2013-03-15
申请人: ARIAD PHARMACEUTICALS, INC. , Zhu, Xiaotian , Wang, Yihan , Shakespeare, William C. , Huang, Wei-Sheng , Dalgarno, David C.
发明人: ZHU, Xiaotian , WANG, Yihan , SHAKESPEARE, William, C. , HUANG, Wei-Sheng , DALGARNO, David, C.
IPC分类号: C07D239/48
摘要: The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of Formula (I), wherein the variables are as defined herein.
-
-
-
-